Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant
暂无分享,去创建一个
J. Tavernier | N. Kley | X. Saelens | F. Peelman | L. Van Hoecke | S. Gerlo | S. Van Lint | G. Uzé | Elianne Burg | Bram Van Den Eeckhout
暂无分享,去创建一个
J. Tavernier | N. Kley | X. Saelens | F. Peelman | L. Van Hoecke | S. Gerlo | S. Van Lint | G. Uzé | Elianne Burg | Bram Van Den Eeckhout